{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T15:27:52Z","timestamp":1648999672697},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T00:00:00Z","timestamp":1535932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00108-018-0485-3","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T07:31:46Z","timestamp":1535959906000},"page":"1063-1073","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetische Herzerkrankungen und Speichererkrankungen mit kardialer Beteiligung"],"prefix":"10.1007","volume":"59","author":[{"given":"Frauke S.","family":"Czepluch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Hasenfu\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,3]]},"reference":[{"key":"485_CR1","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1161\/CIRCGENETICS.113.000085","volume":"6","author":"J Punetha","year":"2013","unstructured":"Punetha J, Hoffman EP (2013) Short read (next-generation) sequencing: a\u00a0tutorial with cardiomyopathy diagnostics as an exemplar. Circ Cardiovasc Genet 6:427\u2013434","journal-title":"Circ Cardiovasc Genet"},{"key":"485_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12181-014-0636-2","volume":"9","author":"E Schulze-Bahr","year":"2015","unstructured":"Schulze-Bahr E, Klaassen S, Abdul-Khaliq H et al (2015) Molecular diagnostics of cardiovascular diseases. Expert consensus statement by the German Cardiac Society (DGK) and the German Society of Pediatric Cardiology (DGPK). Kardiologe 9:213\u2013243","journal-title":"Kardiologe"},{"key":"485_CR3","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1161\/CIRCULATIONAHA.111.062182","volume":"124","author":"PJ Schwartz","year":"2011","unstructured":"Schwartz PJ, Crotti L (2011) QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation 124:2181\u20132184","journal-title":"Circulation"},{"key":"485_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00059-017-4583-0","volume":"42","author":"B Stallmeyer","year":"2017","unstructured":"Stallmeyer B, Dittmann S, Seebohm G et\u00a0al (2017) Molecular genetic diagnostics for ventricular arrhythmias and sudden cardiac death syndromes. Herz 42:476\u2013484","journal-title":"Herz"},{"key":"485_CR5","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1253\/circj.CJ-16-0326","volume":"80","author":"KV Lieve","year":"2016","unstructured":"Lieve KV, van der Werf C, Wilde AA (2016) Catecholaminergic polymorphic ventricular tachycardia. Circ\u00a0J 80:1285\u20131291","journal-title":"Circ J"},{"key":"485_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.acvd.2016.09.009","volume":"110","author":"JP Gourraud","year":"2017","unstructured":"Gourraud JP, Barc J, Thollet A et\u00a0al (2017) Brugada syndrome: diagnosis, risk stratification and management. Arch Cardiovasc Dis 110:188\u2013195","journal-title":"Arch Cardiovasc Dis"},{"key":"485_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","volume":"29","author":"P Elliott","year":"2008","unstructured":"Elliott P, Andersson B, Arbustini E et\u00a0al (2008) Classification of the cardiomyopathies: a\u00a0position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart\u00a0J 29:270\u2013276","journal-title":"Eur Heart J"},{"key":"485_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jacc.2009.02.075","volume":"54","author":"JM Bos","year":"2009","unstructured":"Bos JM, Towbin JA, Ackerman MJ (2009) Diagnostic, prognostic, and therapeutic implications of enetic testing for hypertrophic cardiomyopathy. J\u00a0Am Coll Cardiol 54:201\u2013211","journal-title":"J Am Coll Cardiol"},{"key":"485_CR9","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.4330\/wjc.v6.i12.1234","volume":"6","author":"B Pinamonti","year":"2014","unstructured":"Pinamonti B, Brun F, Mestroni L et\u00a0al (2014) Arrhythmogenic right ventricular cardiomyopathy: from genetics to diagnostic and therapeutic challenges. World J Cardiol 6:1234\u20131244","journal-title":"World J Cardiol"},{"key":"485_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1750-1172-1-27","volume":"1","author":"MRG Taylor","year":"2006","unstructured":"Taylor MRG, Carniel E, Mestroni L (2006) Cardiomyopathy, familial dilated. Orphanet J Rare Dis 1:27","journal-title":"Orphanet J. Rare Dis."},{"key":"485_CR11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/CIRCRESAHA.113.300282","volume":"113","author":"TJ Cahill","year":"2013","unstructured":"Cahill TJ, Ashrafian H, Watkins H (2013) Genetic cardiomyopathies causing heart failure. Circ Res 113:660\u2013675","journal-title":"Circ Res"},{"key":"485_CR12","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jacc.2016.05.096","volume":"68","author":"E Arbustini","year":"2016","unstructured":"Arbustini E, Favalli V, Narula N et\u00a0al (2016) Left ventricular Noncompaction: a distinct genetic cardiomyopathy? J\u00a0Am Coll Cardiol 68:949\u2013966","journal-title":"J Am Coll Cardiol"},{"key":"485_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/TACG.S96233","volume":"9","author":"G Pepe","year":"2016","unstructured":"Pepe G, Giusti B, Sticchi E et\u00a0al (2016) Marfan syndrome: current perspectives. Appl Clin Genet 9:55\u201365","journal-title":"Appl Clin Genet"},{"key":"485_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/bjh.12286","volume":"161","author":"JH Pinney","year":"2013","unstructured":"Pinney JH, Smith CJ, Taube JB et\u00a0al (2013) Systemic amyloidosis in England: an epidemiological study. Br J Haematol 161:525\u2013532","journal-title":"Br J Haematol"},{"key":"485_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3109\/13506129.2014.964858","volume":"21","author":"JD Sipe","year":"2014","unstructured":"Sipe JD, Benson MD, Buxbaum JN et\u00a0al (2014) Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid 21:221\u2013224","journal-title":"Amyloid"},{"key":"485_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00108-011-2952-y","volume":"53","author":"S Sch\u00f6nland","year":"2012","unstructured":"Sch\u00f6nland S, Blank N, Kristen AV et\u00a0al (2012) Systemic amyloidoses. Internist 53:51\u201364","journal-title":"Internist"},{"key":"485_CR17","doi-asserted-by":"publisher","first-page":"9629","DOI":"10.1073\/pnas.1121005109","volume":"24","author":"CE Bulawa","year":"2012","unstructured":"Bulawa CE, Connelly S, DeVit M et\u00a0al (2012) Tafamidis, a\u00a0potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci USA 24:9629\u20139634","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"485_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.beem.2014.10.003","volume":"29","author":"N Seydelmann","year":"2015","unstructured":"Seydelmann N, Wanner C, St\u00f6rk S et\u00a0al (2015) Fabry disease and the heart. Best Pract Res Clin Endocrinol Metab 29:195\u2013204","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"485_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1750-1172-5-30","volume":"5","author":"DP Germain","year":"2010","unstructured":"Germain DP (2010) Fabry disease. Orphanet J Rare Dis 5:30","journal-title":"Orphanet J Rare Dis"},{"key":"485_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13023-015-0253-6","volume":"10","author":"M Biegstraaten","year":"2015","unstructured":"Biegstraaten M, Arngrimsson R, Barbey F et\u00a0al (2015) Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document. Orphanet J Rare Dis 10:36","journal-title":"Orphanet J Rare Dis"},{"key":"485_CR21","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1056\/NEJMoa1510198","volume":"375","author":"DP Germain","year":"2016","unstructured":"Germain DP, Hughes DA, Nicholls K (2016) Treatment of Fabry\u2019s disease with the pharmacologic chaperone Migalastat. N\u00a0Engl J Med 375:545\u2013555","journal-title":"N Engl J Med"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-018-0485-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-018-0485-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-018-0485-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T23:04:20Z","timestamp":1567465460000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-018-0485-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,3]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["485"],"URL":"https:\/\/doi.org\/10.1007\/s00108-018-0485-3","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,3]]},"assertion":[{"value":"3 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.S.\u00a0Czepluch und G.\u00a0Hasenfu\u00df geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}